当前位置:首页 > 关于我们 > 创投导师 > 钟晓林

钟晓林 | Forrest Zhong


图片1.png

钟晓林博士

前担任深圳图灵资产管理有限公司的董事长以及深圳图灵创业投资合伙企业(有限合伙)的创始合伙人 他同时还是国家科技成果转化引导基金创业投资子基金---宁波高灵股权投资基金的合伙人及投委会委员。曾担任华盈创投执行董事及合伙人 (TDF Capital) 以及美国硅谷顶尖创投公司凯鹏华盈中国基金的创始/管理合伙人(KPCB - Kleiner Perkins Caufield & Byers)2007年入选《环球企业家》和投中集团」的投资金手指名单;2008年至2017年连续被《福布斯》(中文版) 评为中国最佳的创业投资人之一

 

投资领域:信息通信技术; 绿色科技,生命科技 。主导的成功投资案例有阳光电源(深圳创业板:300274),视觉(中国)(深圳中小板:000681),金斯瑞生物(香港主板:01548),A8音乐集团(香港主板:00800),宇龙酷派(香港主板:02369),国人通讯(纳斯达克:GRRF),驴妈妈旅游网(新三板上市),百纳科技(海豚浏览器,并购),米络科技(KK唱响/直播,并购),亿动广告传媒(并购),飞博创(并购),握奇数据(并购),康辉医疗(并购),深圳宇星科技(并购),立凯电能(台湾OTC上柜) 等

  

Forrest Zhong is currently the Chairman of Shenzhen Turing Capital Management Co. Ltd. and the founding partner of Shenzhen Turing Venture Capital LLP.  He is also a partner and member of the Investment Committee of Ningbo GolinX Equity Investment LLP – A Venture Capital arm of Chinese National Guiding Fund for Commercialization of Science & Technology Achievements. Dr. Zhong had been a managing director & general partner of TDF Capital – a leading VC fund focusing on early to growth venture opportunities in Chinaas well as a founding and managing partner of KPCB (Kleiner Perkins Caufield & Byers) China Fund.

 

Dr. Zhong”s investment areas include ICT, Green-tech, as well as life-tech. He has backed a number of successful IPOs and M&As, including GenScript Biotech (HKSE: 01548), SunGrow Power (SZSE: 300274), Visual China Group (SZSE: 000681), LvMaMa Online Travel (China OTC: 835188), A8 Digital Music (HKSE: 00800), Coolpad Group (HKSE: 02369), SinoSun Tech (SZSE: 300333), China GrenTech (NASDAQ: GRRF), and Dolphin Browser (M&A ),  KKTV Mobile (M&A); MADHouse Media (M&A), Fiberxon (M&A), and WatchData (M&A), and Aleees Power (Taiwan OTC).

 

Dr. Zhong was named in the Midas list by the Global Entrepreneurs and ChinaVenture in 2007; and was selected as one of the Best Venture Capitalists in China by Forbes (Chinese Edition) from 2008 to 2017 consecutively.


0.185004s